Life Sciences investor LSP is set to being acquired by Europe’s largest equity specialist EQT AB.
 

Two European oncology biopharma companies have made the leap onto the stock market: French MaaT Pharma went public on Euronext Paris, while Danish IO Biotech chose Nasdaq Global Market for its IPO.

European life science investor LSP has raised €850m for its 7th generation flagship fund LSP 7.

Cambridge-based Mogrify Limited announced the appointment of Tom Graney CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor.

Dunad Therapeutics Ltd had entered into a $1.3bn option deal with Swiss pharma major Novartis AG to develop targeted protein degrader therapies.

New, ongoing, free event series about researchers work in the exciting fields of multi-omics. Each session will take a particular field of omics research and showcase some of the exciting research being undertaken from around the world.

Easier access for central European companies to cryo-EM technique! A modern Thermo Scientific ™ Glacios ™ transmission electron microscope has just been installed at Synchrotron Solaris in Poland and it is open for industrial users.

Luxembourg-headquartered Covis is taking two COPD drugs off AstraZeneca’s hands in a US$270m deal.

This white paper focuses on a new generation of single-use bioreactors, built to deliver high-volume performance and how they address many issue.

Eisbach Bio GmbH is a spin-off of the Ludwig Maximilian University in Munich. The company is located in the Innovation and Start-up Centre IZB in Planegg-Martinsried.